[Peritoneal tuberculosis masked by fluoroquinolones in a patient with liver cirrhosis].
Wesenfelder
L
L
Eugène
C
C
D000900:Anti-Bacterial Agents; D001201:Ascites / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009643:Norfloxacin / Q000627:therapeutic use*; D015366:Pefloxacin / Q000627:therapeutic use*; D014395:Peritonitis, Tuberculous / Q000150:complications* / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D015366:Pefloxacin; D009643:Norfloxacin
Tuberculose péritonéale décapitée par les fluoroquinolones chez un malade atteint de cirrhose.